EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation

Stock Information for EDAP TMS S.A.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About EDAP TMS S.A.

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.